TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3873345

Group type: EXPERIMENTAL
Intervention: Murine antihuman T-cell monoclonal antibody (mcAb) therapy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Horse antihuman thymocyte globulin (ATG)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Subsequent treatment with ATG after mcAb failure
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Toxicity of mcAb therapy
Number of subjects: 25
Study: 29083030

Group type: EXPERIMENTAL
Intervention: David's score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized Elo-rating
Number of subjects: 0

Group type: COMPARATOR
Intervention: Original Elo-rating
Number of subjects: 0

Group type: COMPARATOR
Intervention: I&SI
Number of subjects: 0

Group type: COMPARATOR
Intervention: ADAGIO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two simple methods for estimating uncertainty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ratio of observed interactions to individuals
Number of subjects: 0
Study: 27180107

Group type: EXPERIMENTAL
Intervention: Higher NMR (faster nicotine metabolism) in White smokers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher NMR (faster nicotine metabolism) in African American smokers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NMR groups and cotinine levels in African Americans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CYP2A6 enzyme activity in African Americans
Number of subjects: 0
Study: 24595629

Group type: EXPERIMENTAL
Intervention: intensive glycemia treatment
Number of subjects: 10251

Group type: EXPERIMENTAL
Intervention: intensive BP treatment
Number of subjects: 10251

Group type: EXPERIMENTAL
Intervention: both intensive glycemia and BP treatment
Number of subjects: 10251

Group type: COMPARATOR
Intervention: standard lipid/intensive glycemia
Number of subjects: 10251
Study: 22734371

Group type: EXPERIMENTAL
Intervention: Three-line puncture on the Governor Vessel and Bladder Meridian
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine acupuncture (Yintang, Fengchi, Sishencong, Baihui, Shenting, Shangxing)
Number of subjects: 60
Study: 20367677

Group type: EXPERIMENTAL
Intervention: Camouflage lessons
Number of subjects: 0

Group type: COMPARATOR
Intervention: No camouflage (Control)
Number of subjects: 0
Study: 19160946

Group type: EXPERIMENTAL
Intervention: Soldiers in close contact with the CPP
Number of subjects: 226

Group type: COMPARATOR
Intervention: Comparison group of male veteran soldiers with no CPP exposure
Number of subjects: 226
Study: 16027568

Group type: EXPERIMENTAL
Intervention: Hospital-based case management (CM) interventions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hospital-based case management (CM) interventions for patients with heart failure
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hospital-based case management (CM) interventions for stroke patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hospital-based case management (CM) interventions for frail elders
Number of subjects: 12
Study: 14606672

Group type: EXPERIMENTAL
Intervention: Dual‐Bootstrap Iterative Closest Point (Dual‐Bootstrap ICP) algorithm
Number of subjects: 6000
Study: 11010056

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) stimulation
Number of subjects: 61

Group type: COMPARATOR
Intervention: No electrical stimulation
Number of subjects: 61
Study: 8994323

Group type: EXPERIMENTAL
Intervention: SPf66 malaria vaccine
Number of subjects: 1257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1257
Study: 1292325

Group type: EXPERIMENTAL
Intervention: Multi-allergen enzymatic screening immunoassay (Profilo, Bio-Allergy)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Skin prick test (SPT, Phazet, Pharmacia)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pharmacia CAP System
Number of subjects: 80
Study: 3838218

Group type: EXPERIMENTAL
Intervention: Milk supplementation (24 oz per day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 22
Study: 30777526

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Desflurane and Sevoflurane
Number of subjects: 80
Study: 29863695

Group type: EXPERIMENTAL
Intervention: Antidepressant + tranquilizer + antipsychotic agent
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antidepressant + tranquilizer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antidepressant + tranquilizer + mood stabilizer
Number of subjects: 100
Study: 26792353

Group type: EXPERIMENTAL
Intervention: Needle assisted endoscopic group (NE group, n=81)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Conventional endoscopic group (CE group, n=64)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 145
Study: 24486564

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) for BC, 6-week program
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) for BC
Number of subjects: 142
Study: 22337244

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once weekly
Number of subjects: 181

Group type: COMPARATOR
Intervention: Sulfasalazine up to 3 g daily
Number of subjects: 181
Study: 20089727

Group type: EXPERIMENTAL
Intervention: Child-only snack group (LOC eating)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Child-only snack group (high recurrent LOC eating)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Parents of children with LOC eating
Number of subjects: 120

Group type: COMPARATOR
Intervention: Overall mealtime interactions
Number of subjects: 120

Group type: COMPARATOR
Intervention: Predictors of food intake
Number of subjects: 120
Study: 17438247

Group type: EXPERIMENTAL
Intervention: Endonasal laser‐assisted DCR (ELADCR)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Conventional external dacrocystorhinostomy (ext DCR)
Number of subjects: 210
Study: 15632821

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (300 mg/d for 2 weeks preoperatively)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 11773297

Group type: EXPERIMENTAL
Intervention: Anthracycline-based chemotherapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-anthracycline-based adjuvant therapies
Number of subjects: 0
Study: 9990213

Group type: EXPERIMENTAL
Intervention: Continuous epidural block‐oxygen‐nitrous oxide
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Continuous epidural block‐oxygen‐air
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Fentanyl-oxygen-nitrous oxide
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Fentanyl-oxygen-air
Number of subjects: 78
Study: 8062524

Group type: EXPERIMENTAL
Intervention: Stable isotope 54Fe (2.8 mg) given in aqueous form
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stable isotope 54Fe (2.8 mg) taken with a meat meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: Whole body counting using radioisotope 59Fe
Number of subjects: 10
Study: 3302874

Group type: EXPERIMENTAL
Intervention: Clavulanic acid-amoxicillin (ACA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Josamycin (J)
Number of subjects: 32
Study: 31607191

Group type: EXPERIMENTAL
Intervention: Mindfulness-based art therapy (MBAT)
Number of subjects: 84
Study: 29888288

Group type: EXPERIMENTAL
Intervention: Intensive coaching
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Lightweight coaching
Number of subjects: 330

Group type: COMPARATOR
Intervention: Scale-only group
Number of subjects: 330

Group type: COMPARATOR
Intervention: Livongo participation alone
Number of subjects: 330
Study: 27358419

Group type: EXPERIMENTAL
Intervention: PROCOMIDA (food assistance program)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (no food assistance program)
Number of subjects: 63
Study: 23710617

Group type: EXPERIMENTAL
Intervention: Web-based problem-solving intervention (CAPS; n = 65)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Internet resource comparison (IRC; n = 67)
Number of subjects: 132
Study: 23380178

Group type: COMPARATOR
Intervention: Inhaled fluticasone propionate 100 µg twice daily plus placebo tablet once daily
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 100 µg and salmeterol 50 µg twice daily (combination inhaler) plus placebo tablet once daily
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 100 µg twice daily plus montelukast 5-mg tablet once daily
Number of subjects: 63
Study: 21979989

Group type: EXPERIMENTAL
Intervention: Octreotide (100 µg twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 24
Study: 19092696

Group type: EXPERIMENTAL
Intervention: Prolonged rowing training session (approximately 2 h, distance = 20.7 ± 1.4 km, HR = 133 ± 4 bpm, intensity = 80.2 ± 1.6% of HR turn point)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Prolonged rowing training session
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control trial (rest and blood collection)
Number of subjects: 9
Study: 16581422

Group type: EXPERIMENTAL
Intervention: Subthreshold 810-nm-diode laser treatment
Number of subjects: 244

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 244
Study: 12713206

Group type: EXPERIMENTAL
Intervention: Interventions tested during a 12-week period in Phase 1 of GEMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phase 2 interventions
Number of subjects: 0
Study: 10650834

Group type: EXPERIMENTAL
Intervention: 3D radiotherapy planning (3D RTP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2D radiotherapy planning (2D RTP)
Number of subjects: 20
Study: 9052452

Group type: EXPERIMENTAL
Intervention: Endoscopic treatment for severe peptic ulcer haemorrhage
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Maintenance acid-reducing therapy
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Surviving patients
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Patients who rebleed
Number of subjects: 121
Study: 7839897

Group type: EXPERIMENTAL
Intervention: 50g glucose
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: High carbohydrate meal
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Diabetics with glycosuria
Number of subjects: 69

Group type: COMPARATOR
Intervention: Controlled diabetics
Number of subjects: 69
Study: 6669632

Group type: EXPERIMENTAL
Intervention: zopiclone 7.5 mg p.o. nightly for 21 days followed by placebo for 7 days
Number of subjects: 9

Group type: COMPARATOR
Intervention: placebo nightly for 21 days followed by placebo for 7 days
Number of subjects: 9
Study: 30663324

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 29751442

Group type: EXPERIMENTAL
Intervention: HEPA filter air cleaners
Number of subjects: 540

Group type: COMPARATOR
Intervention: Control (no air cleaners)
Number of subjects: 540
Study: 26298839

Group type: EXPERIMENTAL
Intervention: Genuine acupuncture (n=40)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Sham acupuncture (n=44)
Number of subjects: 123

Group type: COMPARATOR
Intervention: No treatment (n=39)
Number of subjects: 123
Study: 25112080

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at bilateral Tianshu (ST 25) and Dachangshu (BL 25) in front‐mu and back‐shu points group
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at bilateral Quchi (LI 11) and Shangjuxu (ST 37) in he‐sea points group
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at unilateral Tianshu (ST 25), Dachangshu (BL 25), Quchi (LI 11) and Shangjuxu (ST 37) in he‐sea, front‐mu and back‐shu points group
Number of subjects: 104

Group type: COMPARATOR
Intervention: Mosapride citrate tablets (5 mg, 3 times a day for 4 weeks) in western medication control group
Number of subjects: 104
Study: 22027844

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 750

Group type: COMPARATOR
Intervention: Generic SSRIs
Number of subjects: 750
Study: 21092175

Group type: EXPERIMENTAL
Intervention: High cocoa liquor/polyphenol rich chocolate (HCL/PR)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Simulated iso‐calorific chocolate (CLF/LP)
Number of subjects: 10
Study: 17379918

Group type: EXPERIMENTAL
Intervention: Proprioceptive training
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Orthoses
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 16456392

Group type: EXPERIMENTAL
Intervention: Family-centered problem-solving intervention (FPS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 32
Study: 15275749

Group type: EXPERIMENTAL
Intervention: Brief rehabilitative psychologically based pain management programme (PMP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PMP group post-hip replacement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group post-hip replacement
Number of subjects: 40
Study: 11020558

Group type: EXPERIMENTAL
Intervention: 70 Gy
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: 78 Gy
Number of subjects: 189

Group type: COMPARATOR
Intervention: 70 Gy and 78 Gy
Number of subjects: 189
Study: 8787889

Group type: EXPERIMENTAL
Intervention: Imipenem plus cilastatin (1 g each)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Meropenem (1 g)
Number of subjects: 12
Study: 1642690

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0
Study: 6337495

Group type: EXPERIMENTAL
Intervention: Dexamethasone (steroid hormone)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 30336703

Group type: EXPERIMENTAL
Intervention: XR-naltrexone (380 mg initially, then monthly doses)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral naltrexone (50 mg daily)
Number of subjects: 60
Study: 28645934

Group type: EXPERIMENTAL
Intervention: Cardiac troponin T
Number of subjects: 4796

Group type: EXPERIMENTAL
Intervention: Cardiac troponin I
Number of subjects: 4796

Group type: EXPERIMENTAL
Intervention: N-terminal pro-B-type natriuretic peptide
Number of subjects: 4796

Group type: EXPERIMENTAL
Intervention: ABC stroke score at 2 months
Number of subjects: 4796

Group type: EXPERIMENTAL
Intervention: Prognostic value for mortality
Number of subjects: 4796

Group type: EXPERIMENTAL
Intervention: Prognostic value for stroke
Number of subjects: 4796

Group type: EXPERIMENTAL
Intervention: Calibration of ABC stroke score
Number of subjects: 4796
Study: 25635400

Group type: EXPERIMENTAL
Intervention: Major key music
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Minor key music
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 29
Study: 24002511

Group type: EXPERIMENTAL
Intervention: TAC × 8 (docetaxel, doxorubicin, and cyclophosphamide)
Number of subjects: 2072

Group type: EXPERIMENTAL
Intervention: TAC-NX (vinorelbine and capecitabine)
Number of subjects: 2072

Group type: EXPERIMENTAL
Intervention: Response-guided chemotherapy (TAC × 8 or TAC-NX)
Number of subjects: 2072

Group type: COMPARATOR
Intervention: TAC × 6
Number of subjects: 2072
Study: 21253869

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy
Number of subjects: 0
Study: 19103885

Group type: EXPERIMENTAL
Intervention: Consistent condom use
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: At least one use of condoms
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Always use of condoms
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: One-time sexual partnerships
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Partnership frequency >30 times
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: One-time partnerships
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Main partnerships
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: New partnerships
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Non-new partnerships
Number of subjects: 2125
Study: 16534538

Group type: EXPERIMENTAL
Intervention: Clinical quality management intervention
Number of subjects: 338
Study: 14530847

Group type: EXPERIMENTAL
Intervention: Endoscopic control (E-group)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Percutaneous suture without endoscopy (P-group)
Number of subjects: 156
Study: 10787067

Group type: EXPERIMENTAL
Intervention: Continuous Hyperthermic Peritoneal Perfusion (CHPP) with saline solution containing 150 to 300 mg cisplatin and 30 to 60 mg mitomycin C for 60 minutes at 42.0 degrees C (n = 9)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Continuous Normothermic Peritoneal Perfusion (CNPP) with saline solution containing 150 to 300 mg cisplatin and 30 to 60 mg mitomycin C for 60 minutes at 37.0 degrees C (n = 7)
Number of subjects: 16
Study: 8982739

Group type: EXPERIMENTAL
Intervention: Ethinyl oestradiol (50 micrograms daily for 14 days)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Oestrone sulphate (2.5 mg daily for 14 days)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 1470134

Group type: EXPERIMENTAL
Intervention: EIS
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ET
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: DSRS
Number of subjects: 96
Study: 6486869

Group type: EXPERIMENTAL
Intervention: Continuous phototherapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (one in four hours of irradiation)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Intermittent phototherapy (other regimen)
Number of subjects: 34
Study: 31723163

Group type: EXPERIMENTAL
Intervention: 45PBM + HI (45% PBM supplemented with 10% HI)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: 90PBM + HI (90% PBM supplemented with 10% HI)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control (FM based diet)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: 45PBM + HI
Number of subjects: 225
Study: 29971996

Group type: EXPERIMENTAL
Intervention: Preoperative moxibustion
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Postoperative moxibustion
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108
Study: 26979237

Group type: EXPERIMENTAL
Intervention: Lavage self-sampling device
Number of subjects: 12075

Group type: EXPERIMENTAL
Intervention: Brush self-sampling device
Number of subjects: 12075
Study: 25265444

Group type: EXPERIMENTAL
Intervention: Back School program (group A)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Hydrotherapy program (group B)
Number of subjects: 56
Study: 22621376

Group type: EXPERIMENTAL
Intervention: Culturally targeted intervention consisting of dietary counseling using motivational interviewing and a supervised physical activity program
Number of subjects: 536

Group type: COMPARATOR
Intervention: Generic lifestyle advice
Number of subjects: 536
Study: 20930300

Group type: EXPERIMENTAL
Intervention: Rosiglitazone XR
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 17434437

Group type: EXPERIMENTAL
Intervention: CP‐675,206 immunotherapy
Number of subjects: 20
Study: 15867490

Group type: EXPERIMENTAL
Intervention: HCV-specific IFNgamma production
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: IFNgamma production in response to NS5 and summed HCV proteins
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: IFNgamma production in response to Candida
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: IFNgamma responses to Candida and summed HCV proteins
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: HIV viral load and HCV viral load
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Undetectable HIV viral load and higher IFNgamma response to Candida
Number of subjects: 107
Study: 11532477

Group type: EXPERIMENTAL
Intervention: Nafarelin acetate (200 microg b.i.d. for 7 days followed by 200 microg daily)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Buserelin acetate (300 microg t.i.d.)
Number of subjects: 352
Study: 9506565

Group type: EXPERIMENTAL
Intervention: Combination of weekly oral methotrexate and daily azathioprine (MTX/AZA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravenous methotrexate with leucovorin rescue (I.V. MTX)
Number of subjects: 30
Study: 7827349

Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetic patients with microalbuminuria
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Macroalbuminuric patients
Number of subjects: 104

Group type: COMPARATOR
Intervention: Non-diabetic control subjects
Number of subjects: 104
Study: 11039059

Group type: EXPERIMENTAL
Intervention: Fluoridated toothpaste systems (five different types)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Non-fluoridated toothpaste
Number of subjects: 27
Study: 30027174

Group type: EXPERIMENTAL
Intervention: Ozone (O3) for 60 seconds
Number of subjects: 32

Group type: COMPARATOR
Intervention: 38% Hydrogen peroxide (H2O2) for 20 minutes
Number of subjects: 32
Study: 28685824

Group type: EXPERIMENTAL
Intervention: Intraoperative music application
Number of subjects: 135

Group type: COMPARATOR
Intervention: No music (control group)
Number of subjects: 135
Study: 26578409

Group type: EXPERIMENTAL
Intervention: 1500 mg/day arginyl-fructose
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 23643233

Group type: EXPERIMENTAL
Intervention: Original 7-point checklist (7PCL)
Number of subjects: 1436

Group type: EXPERIMENTAL
Intervention: Weighted 7-point checklist (7PCL)
Number of subjects: 1436

Group type: EXPERIMENTAL
Intervention: Weighted 7PCL with revised cut-off score of 4
Number of subjects: 1436
Study: 21123462

Group type: EXPERIMENTAL
Intervention: Galactose drink
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glucose drink
Number of subjects: 14
Study: 18978625

Group type: EXPERIMENTAL
Intervention: Conventional resistance training (CRT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Plyometric training (PT)
Number of subjects: 15
Study: 16782488

Group type: EXPERIMENTAL
Intervention: CD4-guided HAART (CD4GT)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Continuous HAART (CT)
Number of subjects: 326
Study: 14994604

Group type: EXPERIMENTAL
Intervention: Amoxycillin with potassium clavulanate (subgroup A)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Cefuroxime axetil (subgroup B)
Number of subjects: 115